FDA Approves 225 ANDAs, 46 "First Generics" Including Retin-A And Hytrin
Executive Summary
Novartis subsidiary Geneva will market Spear Pharmaceutical's tretinoin cream following FDA approval of the first generic version of Ortho-McNeil's Retin-A cream Dec. 24.